Daniel L Krah

Title: The Innovations of Daniel L Krah

Introduction

Daniel L Krah is an accomplished inventor based in Lansdale, PA (US). He is known for his significant contributions to the field of virology, particularly in the development of vaccines. His work has the potential to impact public health positively by addressing respiratory syncytial virus (RSV) infections.

Latest Patents

Krah holds 1 patent for his invention titled "Live, attenuated respiratory syncytial virus." This innovative patent features live, attenuated respiratory syncytial viruses that are useful as vaccines against RSV infection and the development of severe RSV-associated illnesses. The disclosed viruses are designed to be nonpathogenic when administered to a subject while retaining the antigenic and immunogenic properties of wild-type RSV.

Career Highlights

Daniel L Krah is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work at Merck has allowed him to focus on groundbreaking research and development in vaccine technology. Krah's dedication to his field has positioned him as a key figure in the fight against viral infections.

Collaborations

Throughout his career, Krah has collaborated with notable colleagues, including Mary K Yagodich and Michael P Citron. These partnerships have fostered an environment of innovation and have contributed to the advancement of vaccine research.

Conclusion

Daniel L Krah's contributions to the field of virology and vaccine development are noteworthy. His innovative work on live, attenuated respiratory syncytial viruses showcases his commitment to improving public health through scientific advancements.